Indicators

Markets:

News

Latest News about AZN

Recent news which mentions AZN

...

21 22 23 24 25 26 27 28 29

...

FDA Approves AstraZeneca's Imfinzi/Imjudo Chemo Combo For Late Stage Lung Cancer

November 11, 2022

Repeat COVID-19 Infection Increases Risk Of Acute Outcomes, Long COVID Symptoms, Study Shows

November 11, 2022

AstraZeneca PLC (AZN) Q3 2022 Earnings Call Transcript

November 10, 2022

Why AstraZeneca Stock Shot Higher Today

November 10, 2022

Troubled FTX Faces SEC Probe And 'Urgently Needs' $8B To Avoid Bankruptcy, NIO Posts Wider Q3 Loss, AstraZeneca Ditches US Application Submission For COVID-19 Shot: Top Stories Thursday, Nov. 11

November 10, 2022

Apple Hires Facebook Veteran as Information Chief; More Departures Likely

November 10, 2022

Worried About a Recession? Park Your Money In These 2 High-Yielding Dividend Stocks

November 10, 2022

AstraZeneca Ditches US Application Submission For COVID-19 Shot, Q3 Edges Analyst Expectations On Oncology Strength

November 10, 2022

AstraZeneca lifts guidance after forecast-beating profit and sales

November 10, 2022

'Waiting Game Continues' In Emergent BioSolutions, Analysts Cut Price Target

November 09, 2022

FDA Adcomm Backs AstraZeneca's 2-In-1 Asthma Inhaler, Only For Adults Being Less Sure For Adolescents, Kids

November 09, 2022

Options Traders Expect AstraZeneca Shares To Fall After Earnings Report, As Stock Is Up 5% In 2022

November 09, 2022

Why Are Apellis Pharmaceuticals Shares Falling Today?

November 04, 2022

Europe Approves AstraZeneca-Sanofi Partnered Antibody To Prevent RSV Infection In Infants

November 04, 2022

Why Horizon Therapeutics' Shares Rose 11.32% on Wednesday

November 02, 2022

Sorrento Has Potential To Deliver Multiple Best-In-Class Products

November 02, 2022

Hurry! 7 Pitiful Nasdaq Stocks to Sell Before 2022 Ends.

November 01, 2022

Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know

November 01, 2022

Hospitalizations on the rise in New York City as new COVID strains spread rapidly

November 01, 2022

European Regulator Grants Complete Approval To AstraZeneca's COVID-19 Vaccine

November 01, 2022

15 Global Psychedelics Executives To Keep An Eye On In 2022

October 28, 2022

Why Invitae Stock Was So Healthy This Week

October 28, 2022

Ranking 7 Top Tech Stocks to Buy From Biggest to Smallest

October 28, 2022

3 Perfect Stocks Retirees Can Buy Hand Over Fist Right Now

October 28, 2022

AstraZeneca's Ultomiris Showed Zero Relapses In Patients With Chronic Disorder Of Brain, Spinal Cord

October 27, 2022

A New BioTech Research Race Is Focused On Improving Life For MS Patients

October 27, 2022

Intel's Self-Driving Tech Firm Raises Over $800M In IPO, Alphabet Misses Q3 Earnings Expectations, Lyft Cuts Price For Monthly Subscription Plan: Top Stories Wednesday, Oct. 26

October 26, 2022

AstraZeneca Touts Positive Data From Two Experimental Drugs In Breast Cancer Settings

October 26, 2022

AstraZeneca says advanced trial of breast-cancer drug Capivasertib meets primary endpoints

October 26, 2022

Twitter Considers Crypto Wallet, Geopolitical Woes To Keep Tesla Shares Volatile, Juul Explores Possible Bailout: Top Stories Tuesday, Oct. 25

October 25, 2022

...

21 22 23 24 25 26 27 28 29

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.